Monges Viviane 4

What Happened Viviane Monges, a director of ADC Therapeutics (ADCT), received an award of 45,000 restricted stock units (RSUs) on 2026-06-01 (code A). The RSUs were granted at $0.00 per share as an equity award. On 2026-06-03 the issuer withheld 2,596 common shares (code F) to satisfy tax withholding obligations related to RSU vesting; those shares were recorded as disposed at $3.08 each, totaling approximately $7,996. This is a standard director equity grant plus routine tax-withholding, not an open-market purchase or sale for investment.

Key Details

• Transactions reported:
  • 2026-06-01 — Award (A): 45,000 RSUs granted @ $0.00 (each RSU = contingent right to 1 share).
  • 2026-06-03 — Tax withholding (F): 2,596 shares withheld/disposed @ $3.08 = $7,996.
• Vesting terms (footnote): RSUs vest on the earlier of one year from grant or the 2027 Annual Meeting, subject to continued service (F1).
• Withholding note (footnote): The 2,596 shares were withheld by the issuer to satisfy the reporting person’s tax obligations on RSU vesting (F2).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing date: Form 4 filed 2026-06-03; timing appears routine for the reported transactions (no late-filing indication in the excerpt).

Context

• RSU awards are compensation-based grants that convert to stock if/when they vest and are not the same as a market purchase (so they don’t necessarily signal a director’s personal bullish stance).
• The withholding of shares to pay taxes is a common administrative step (reduces net shares received).